# FDA EIR - Shilpa Pharma Lifesciences Limited - March 14, 2025

Source: https://www.globalkeysolutions.net/records/eir/shilpa-pharma-lifesciences-limited/036223cc-3567-4fdd-91cc-d7f0c3dddb4a

> FDA EIR for Shilpa Pharma Lifesciences Limited on March 14, 2025. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Shilpa Pharma Lifesciences Limited
- Inspection Date: 2025-03-14
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2018-01-19](https://www.globalkeysolutions.net/records/483/shilpa-pharma-lifesciences-limited/45380c3a-962d-4d61-a65a-9b306068fc0d)
- [483 - 2019-07-26](https://www.globalkeysolutions.net/records/483/shilpa-pharma-lifesciences-limited/bb6d959f-6c45-457b-8cdc-c587fe992235)

## Related Officers

- [Ankur C. Patel](https://www.globalkeysolutions.net/people/ankur-c-patel/602c7d14-2c48-4929-a07b-6e4c235d7f13)
- [Consumer Safety Officer at FDA](https://www.globalkeysolutions.net/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)

Company: https://www.globalkeysolutions.net/companies/shilpa-pharma-lifesciences-limited/4f617c67-eea7-483d-b9c7-b1dd31aabcff

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c